Workflow
Kymera Therapeutics(KYMR) - 2024 Q4 - Annual Results

Exhibit 99.2 January 2025 J.P. Morgan Healthcare Conference Nello Mainolfi, Ph.D., Founder, President and CEO ,KYMERA This presentation contains forward-looking statements within the meanine of the Private Securities Litiation Reform Act of 1995 and other federal securities laws. These statements include, but are not limited to, inplied and express statements about our stratesy, business plans and digictives for the inclinerines for the preclinical and cl regarding timing, success and data announcements of ...